Table II.
The demographics and comorbidities in the vicryl (standard suture) and the vicryl plus (triclosan-coated) suture groups
Characteristic | Vicryl (n = 1323) | Vicryl+(n = 1223) | p-value* |
---|---|---|---|
Mean age, yrs (sd) | 67.2 (9.7) | 67.5 (10) | 0.564 |
Gender, female:male (% female) | 719:604 (54.4) | 660:563 (54) | 0.879 |
Operation, n (%) | 0.782 | ||
Hip | 590 (46.3) | 532 (45.7) | |
Knee | 683 (53.7) | 632 (54.3) | |
Site, n (%) | < 0.001 | ||
Hexham Hospital | 495 (38.9) | 493 (40.3) | |
NTG Hospital | 150 (11.8) | 200 (16.4) | |
Wansbeck General Hospital | 628 (49.3) | 530 (43.3) | |
Medical history available, n (%) | 1273 | 1164 | |
Hypertension | 595 (46.74) | 586 (50.34) | 0.082 |
Atrial fibrillation | 61 (4.79) | 57 (4.9) | 0.979 |
Ischemic Heart Disease | 93 (7.31) | 81 (6.96) | 0.800 |
Hypothyroid | 99 (7.78) | 74 (6.36) | 0.199 |
Type 1 Diabetes | 7 (0.55) | 8 (0.69) | 0.797 |
Type 2 Diabetes | 135 (10.6) | 109 (9.36) | 0.341 |
Peripheral Vas Disease | 54 (4.24) | 66 (5.67) | 0.125 |
COPD | 42 (3.3) | 43 (3.69) | 0.674 |
Dementia | 1 (0.08) | 1 (0.09) | 1.000 |
Alzheimers | 2 (0.16) | 3 (0.26) | 0.675 |
Pressure sores | 2 (0.16) | 0 (0) | 0.501 |
Psoriatic arthritis | 8 (0.63) | 3 (0.26) | 0.231 |
Rheumatoid arthritis | 34 (2.67) | 21 (1.8) | 0.193 |
Hypercholesterlaemia | 70 (5.5) | 75 (6.44) | 0.369 |
Independent sample t-test
NTG, North Tyneside General; COPD, chronic obstructive pulmonary disease